ISSX New Investigator Group Fireside Chat with Ken Korzekwa

  • Register
    • Non-member - $49
    • Member - Free!
    • Student - Free!
    • Premier - Free!

    Continue

The ISSX New Investigator Group will present a series of Fireside Chats with influential senior scientists in our field. Each chat session will be moderated by a member of the group and the discussion will include wide-ranging topics such as current scientific trends, leveraging your network, and thinking strategically about your career in industry, academia, and/or government.  

About the Speaker:

Dr. Ken Korzekwa, Ph.D. is Professor of Pharmaceutical Sciences at Temple University School of Pharmacy. He received his Ph.D. in Medicinal Chemistry from the University of Washington and was a PRAT fellow, Staff Fellow, and Senior Staff Fellow at the NIH. Prior to joining Temple University, he has been an Associate Professor at the University of Pittsburgh, was involved in two startup companies, and was Director and Distinguished Senior Investigator at Merck. His research interests are developing predictive models for drug metabolism and pharmacokinetics. 

Ken Korzekwa

ISSX New Investigator Group Fireside Chat: A Conversation with Ken Korzekwa, Ph.D.

Dr. Ken Korzekwa, Ph.D.?is Professor of Pharmaceutical Sciences at Temple University School of Pharmacy. He received his Ph.D. in Medicinal Chemistry from the University of Washington and was a PRAT fellow, Staff Fellow, and Senior Staff Fellow at the NIH. Prior to joining Temple University, he has been an Associate Professor at the University of Pittsburgh, was involved in two startup companies, and was Director and Distinguished Senior Investigator at Merck. His research interests are developing predictive models for drug metabolism and pharmacokinetics.?

Key:

Complete
Failed
Available
Locked
ISSX New Investigator Group Fireside Chat with Ken Korzekwa
Recorded 05/03/2022
Recorded 05/03/2022 Dr. Ken Korzekwa, Ph.D. is Professor of Pharmaceutical Sciences at Temple University School of Pharmacy. He received his Ph.D. in Medicinal Chemistry from the University of Washington and was a PRAT fellow, Staff Fellow, and Senior Staff Fellow at the NIH. Prior to joining Temple University, he has been an Associate Professor at the University of Pittsburgh, was involved in two startup companies, and was Director and Distinguished Senior Investigator at Merck. His research interests are developing predictive models for drug metabolism and pharmacokinetics.
You must register to access.